239 related articles for article (PubMed ID: 33649207)
1. IDO1 scavenges reactive oxygen species in myeloid-derived suppressor cells to prevent graft-versus-host disease.
Ju JM; Nam G; Lee YK; Jung M; Chang H; Kim W; Shon WJ; Lim JY; Kim JY; Chang J; Min CK; Lee DS; Choi K; Shin DM; Choi EY
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649207
[TBL] [Abstract][Full Text] [Related]
2. Graft-Versus-Host Disease Prevention by
Scheurer J; Kitt K; Huber HJ; Fundel-Clemens K; Pflanz S; Debatin KM; Strauss G
Front Immunol; 2021; 12():754316. PubMed ID: 34721430
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism.
Joo YD; Lee SM; Lee SW; Lee WS; Lee SM; Park JK; Choi IW; Park SG; Choi I; Seo SK
Immunology; 2009 Sep; 128(1 Suppl):e632-40. PubMed ID: 19740324
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.
Highfill SL; Rodriguez PC; Zhou Q; Goetz CA; Koehn BH; Veenstra R; Taylor PA; Panoskaltsis-Mortari A; Serody JS; Munn DH; Tolar J; Ochoa AC; Blazar BR
Blood; 2010 Dec; 116(25):5738-47. PubMed ID: 20807889
[TBL] [Abstract][Full Text] [Related]
5. MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease.
Lim JY; Lee YK; Lee SE; Ju JM; Eom KS; Kim YJ; Chung NG; Jeong DC; Park G; Choi EY; Min CK
Mucosal Immunol; 2016 May; 9(3):730-43. PubMed ID: 26442657
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity.
Scheurer J; Reisser T; Leithäuser F; Messmann JJ; Holzmann K; Debatin KM; Strauss G
Clin Exp Immunol; 2020 Dec; 202(3):407-422. PubMed ID: 32681646
[TBL] [Abstract][Full Text] [Related]
7. Skewed Dendritic Cell Differentiation of MyD88-Deficient Donor Bone Marrow Cells, Instead of Massive Expansion as Myeloid-Derived Suppressor Cells, Aggravates GVHD.
Lee YK; Ju JM; Shon WJ; Oh S; Min CK; Kang MS; Shin DM; Choi EY
Immune Netw; 2018 Dec; 18(6):e44. PubMed ID: 30619630
[TBL] [Abstract][Full Text] [Related]
8. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
9. Vascular Alterations in a Murine Model of Acute Graft-Versus-Host Disease Are Associated with Decreased Serum Levels of Adiponectin and an Increased Activity and Vascular Expression of Indoleamine 2,3-Dioxygenase.
Schmid PM; Bouazzaoui A; Schmid K; Birner CM; Schach C; Maier LS; Holler E; Endemann DH
Cell Transplant; 2016 Nov; 25(11):2051-2062. PubMed ID: 27196361
[TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
[TBL] [Abstract][Full Text] [Related]
11. IFN-γ differentially regulates subsets of Gr-1(+)CD11b(+) myeloid cells in chronic inflammation.
Zhan X; Fang Y; Hu S; Wu Y; Yang K; Liao C; Zhang Y; Huang X; Wu M
Mol Immunol; 2015 Aug; 66(2):451-62. PubMed ID: 26021804
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
Singh B; Singh DK; Ganatra SR; Escobedo RA; Khader S; Schlesinger LS; Kaushal D; Mehra S
mBio; 2021 Dec; 12(6):e0318921. PubMed ID: 34903057
[TBL] [Abstract][Full Text] [Related]
13. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-Derived Suppressor Cells in
Fresno M; Gironès N
Front Cell Infect Microbiol; 2021; 11():737364. PubMed ID: 34513737
[TBL] [Abstract][Full Text] [Related]
15. Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality.
Jasperson LK; Bucher C; Panoskaltsis-Mortari A; Mellor AL; Munn DH; Blazar BR
Blood; 2009 Dec; 114(24):5062-70. PubMed ID: 19828695
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation.
D'Aveni M; Notarantonio AB; Bertrand A; Boulangé L; Pochon C; Rubio MT
Front Immunol; 2020; 11():989. PubMed ID: 32528476
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice.
Reddy P; Sun Y; Toubai T; Duran-Struuck R; Clouthier SG; Weisiger E; Maeda Y; Tawara I; Krijanovski O; Gatza E; Liu C; Malter C; Mascagni P; Dinarello CA; Ferrara JL
J Clin Invest; 2008 Jul; 118(7):2562-73. PubMed ID: 18568076
[TBL] [Abstract][Full Text] [Related]
18. Increased Galectin-9 expression, a prognostic biomarker of aGVHD, regulates the immune response through the Galectin-9 induced MDSC pathway after allogeneic hematopoietic stem cell transplantation.
Yin J; Li L; Wang C; Zhang Y
Int Immunopharmacol; 2020 Nov; 88():106929. PubMed ID: 32889240
[TBL] [Abstract][Full Text] [Related]
19. Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype.
Köstlin N; Vogelmann M; Spring B; Schwarz J; Feucht J; Härtel C; Orlikowsky TW; Poets CF; Gille C
Immunology; 2017 Sep; 152(1):89-101. PubMed ID: 28464218
[TBL] [Abstract][Full Text] [Related]
20. Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.
Schafer CC; Wang Y; Hough KP; Sawant A; Grant SC; Thannickal VJ; Zmijewski J; Ponnazhagan S; Deshane JS
Oncotarget; 2016 Nov; 7(46):75407-75424. PubMed ID: 27705910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
